A single invitation for a prostate-specific antigen (PSA) screening test results in a small but significant reduction in prostate cancer deaths, but also leads to overdiagnosis and missed early ...

SAN FRANCISCO—Offering PSA testing for free is associated with a reduction in prostate cancer mortality, according to an Austrian study. The study, presented at the American Urological Association ...

PSA blood test A study of 400,887 men in an integrated health system, the first to evaluate various PSA screening intervals and age groups, concluded that yearly screening is the interval of choice.

Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...

Prostate-specific antigen (PSA) screening is associated with decreased risk of prostate cancer-specific mortality (PCSM) among both Black and White men, according to a study published online Aug. 4 in ...

About The Study: A single invitation for prostate-specific antigen (PSA) screening compared with standard practice without routine screening reduced prostate cancer deaths at a median follow-up of 15 ...

Please provide your email address to receive an email when new articles are posted on . PSA screening appeared associated with lower prostate cancer-specific mortality among both black men and ...

This is a large-scale, population-based, observational study of two screening strategies: annual PSA screening and no screening. We used data from 537,599 US Medicare (2001-2008) beneficiaries age ...

Prostate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe. A large randomized trial conducted at Tampere University and ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term follow-up results from the European Randomized Study of Screening for ...